biocon.com

Overview

It is a sub-domain of com. It has a global Alexa ranking #122,244 and ranked 13029th in India. biocon.com receives about 13,511 unique visitors and 67,555 page views per day which should earn about $ 169.00/day from advertising revenue.Estimated site value is $ 101,400.00. According to SiteAdvisor, biocon.com is safe to visit.Its web server is located in India, with IP address 202.154.161.27.

General Info
Title: Biocon - India's largest biopharmaceutical company
Description: Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals....
Keywords: biocon, best biopharma company, top biopharma company, biologics, research services, head and neck cancer, breast cancer, cancer drugs, clinical trials, research, innovation, contract manufacturing, affordable medicines, affordable drugs, medical, biocon share market price, pharma, biotech, biotechnology, pharmaceuticals, biopharmaceuticals, diabetes, insulin, insulin analogs, human insulin, oral insulin, immunosuppressant, immunotherapy, psoriasis, dna, rna, bio product, branded formulations, biosimilar, small molecules, fermentation, monoclonal antibody, recombinant proteins, egfr, gcsf, orlistat, glargine, peptides, aspart, lispro, metabolic, drug, drug manufacturing, stalins, pharmaceutical contract manufacturing, large scale producers, global manufacturers, apis, formulations, injectable, discovery, novel molecules, fusion proteins, integrated branded formulations, diabetology, oncology, nephrology, cardiology, comprehensive care, insugen, basalog, canmab, tacrograf, biomab egfr, renodapt s, psorid, cimivir l, renodapt, insugen n, daclawin, tbis, picon, cymgal, calpsor c, abstet, thinla, evertor, advacan, rapacan, aretha, bionesp, fosaport, genxtor, calpsor, inter acting, fast acting, long acting, trastuzumab recombinant, tacrolimus, oth mab antineoplastics, mycophenolic acid, ciclosporin, ledipasvir, sofosbuvir, mycophenolate mofetil, intermediate acting, daclatasvir, tacrolimus topical, pimecrolimus, valganciclovir, oth clobetasol, antiinf co, abiraterone, heparin, everolimus, sirolimus, azathioprine, darbepoetin prep, fosaprepitant meglumine, oth pki antineoplastics, calcipotriol
Alexa Rank: #122,244
Daily Revenue: $ 169.00
Daily visitors: 13,511
Daily Pageviews: 67,555
Google Analytics: UA-4795378-1
IP Address: 202.154.161.27
Host Location: India
Stats & Details
Global Rank 122,244
Delta -76103
Reach Rank126921
CountryIndia
Rank in Country13029
DNS Records
Host Type TTL Extra
biocon.com A 299 IP: 202.154.161.27
biocon.com NS 86400 Target: hera.ns.cloudflare.com
biocon.com NS 86400 Target: kai.ns.cloudflare.com
biocon.com SOA 3600 MNAME: hera.ns.cloudflare.com
RNAME: dns.cloudflare.com
Serial: 2034714179
Refresh: 10000
Retry: 2400
Expire: 604800
biocon.com MX 300 Target: mx1.hc432.c3s2.iphmx.com
biocon.com MX 300 Priority: 5
Target: mx2.hc432.c3s2.iphmx.com
biocon.com TXT 300 TXT: v=spf1
include:spf.protection.outlook.com
ip4:68.232.151.131 ip4:68.232.159.85
ip4:123.63.251.208 ip4:121.244.94.4
ip4:121.244.95.65 ip4:123.63.251.193
ip4:121.244.94.1 ip4:121.244.94.9
ip4:123.63.251.194 ip4:123.63.251.195
ip4:121.244.94.19 ip4:121.244.94.11
ip4:216.71.139.40 ip4:216.71.159.190
exists:%{i}.spf.hc432.c3s2.iphmx.com
-all
biocon.com TXT 300 TXT: oCE07GnI04LzsW/4HO4ffJCdzvLUkHzqA1OF2aQ6
4TrAdbJPKtQ0gqI8z1AEmBRr0qw6bMybfaPTWNUM
BWFP8Q==
biocon.com TXT 300 TXT: MS=ms82044672
HTTP Header Analysis
HTTP/1.1 200 OK
Cache-Control: private
Content-Type: text/html
Content-Encoding: gzip
Vary: Accept-Encoding
Server: Microsoft-IIS/8.5
X-Frame-Options: SAMEORIGIN
Strict-Transport-Security: max-age=15552001; includeSubDomains; preload
Date: Sat, 25 Jul 2020 18:15:46 GMT
Content-Length: 20713
Similarly Ranked
DomainRank
culturepsg.com#122,247
agriexpo.online#122,247
xxxporn.su#122,247
appone.net#122,250
technoavia.ru#122,250
hollyhood.com.tr#122,251
towbook.com#122,253
gtracing.com#122,255
kontekst.io#122,255
groupswhats.com#122,256
Recently Viewed